Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakagawa, T.
Right arrow Articles by Noguchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakagawa, T.
Right arrow Articles by Noguchi, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 3 436-444, Copyright © 2000 by American Diabetes Association


ARTICLES

Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice

T Nakagawa, A Tsuchida, Y Itakura, T Nonomura, M Ono, F Hirota, T Inoue, C Nakayama, M Taiji and H Noguchi
Sumitomo Pharmaceuticals Research Center, Discovery Research Laboratories II, Osaka, Japan.

We previously reported that brain-derived neurotrophic factor (BDNF) regulates both food intake and blood glucose metabolism in rodent obese diabetic models such as C57BL/KsJ-lepr(db)/lepr(db) (db/db) mice. To elucidate the effect of BDNF on glucose metabolism, we designed a novel pellet pair-feeding apparatus to eliminate the effect of appetite alteration on glucose metabolism. The apparatus was used to synchronize food intake precisely between BDNF-treated and vehicle-treated db/db mice. It was shown using this pellet pair-feeding apparatus that BDNF administered daily (20 mg x kg(-1) x day(-1)) to db/db mice significantly lowered blood glucose compared with pellet pair-fed db/db mice. To evaluate the effect of BDNF on insulin action, we used streptozotocin-induced type 1 diabetic mice. In this case, BDNF did not lower blood glucose concentration but rather enhanced the hypoglycemic action of insulin. In hyperglycemic db/db mice, pancreatic insulin content was reduced and glucagon content was increased compared with normoglycemic db/m mice. BDNF administered to db/db mice significantly restored both pancreatic insulin and glucagon content. Histological observations of aldehyde-fuchsin staining and immunostaining with anti-insulin indicated that insulin-positive pancreatic beta-cells were extensively regranulated by BDNF administration. We also studied the effect of BDNF on KK mice, normoglycemic animals with impaired glucose tolerance. In these mice, BDNF administration improved insulin resistance in the oral glucose tolerance test. To elucidate how blood glucose was metabolized in BDNF-treated animals, we investigated the effect of BDNF on the energy metabolism of db/db mice. Body temperature and oxygen consumption of the pellet pair-fed vehicle-treated mice were remarkably lower than the ad libitum-fed vehicle-treated mice. Daily BDNF administration for 3 weeks completely ameliorated both of the reductions. Finally, to clarify its action mechanism, the effect of intracerebroventricular administration of BDNF on db/db mice was examined. Here, a small dose of BDNF was found to be effective in lowering blood glucose concentration. This indicates that BDNF regulates glucose metabolism by acting directly on the brain.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
J. C. Han, Q.-R. Liu, M. Jones, R. L. Levinn, C. M. Menzie, K. S. Jefferson-George, D. C. Adler-Wailes, E. L. Sanford, F. L. Lacbawan, G. R. Uhl, et al.
Brain-Derived Neurotrophic Factor and Obesity in the WAGR Syndrome
N. Engl. J. Med., August 28, 2008; 359(9): 918 - 927.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Tsao, H. K. Thomsen, J. Chou, J. Stratton, M. Hagen, C. Loo, C. Garcia, D. L. Sloane, A. Rosenthal, and J. C. Lin
TrkB Agonists Ameliorate Obesity and Associated Metabolic Conditions in Mice
Endocrinology, March 1, 2008; 149(3): 1038 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
H. Sha, J. Xu, J. Tang, J. Ding, J. Gong, X. Ge, D. Kong, and X. Gao
Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice
Physiol Genomics, October 19, 2007; 31(2): 252 - 263.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Martin, M. Pearson, L. Kebejian, E. Golden, A. Keselman, M. Bender, O. Carlson, J. Egan, B. Ladenheim, J.-L. Cadet, et al.
Sex-Dependent Metabolic, Neuroendocrine, and Cognitive Responses to Dietary Energy Restriction and Excess
Endocrinology, September 1, 2007; 148(9): 4318 - 4333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Wang, E. Bomberg, C. Billington, A. Levine, and C. M. Kotz
Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R992 - R1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. E. Levin
Neurotrophism and energy homeostasis: perfect together
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R988 - R991.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Wang, E. Bomberg, C. Billington, A. Levine, and C. M. Kotz
Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reduces energy intake
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1003 - R1012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Otabe, X. Yuan, T. Fukutani, N. Wada, T. Hashinaga, H. Nakayama, N. Hirota, M. Kojima, and K. Yamada
Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E210 - E218.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. H. El-Gharbawy, D. C. Adler-Wailes, M. C. Mirch, K. R. Theim, L. Ranzenhofer, M. Tanofsky-Kraff, and J. A. Yanovski
Serum Brain-Derived Neurotrophic Factor Concentrations in Lean and Overweight Children and Adolescents
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3548 - 3552.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
S. Vaynman and F. Gomez-Pinilla
License to Run: Exercise Impacts Functional Plasticity in the Intact and Injured Central Nervous System by Using Neurotrophins
Neurorehabil Neural Repair, December 1, 2005; 19(4): 283 - 295.
[Abstract] [PDF]


Home page
EndocrinologyHome page
R. Kouyama, T. Suganami, J. Nishida, M. Tanaka, T. Toyoda, M. Kiso, T. Chiwata, Y. Miyamoto, Y. Yoshimasa, A. Fukamizu, et al.
Attenuation of Diet-Induced Weight Gain and Adiposity through Increased Energy Expenditure in Mice Lacking Angiotensin II Type 1a Receptor
Endocrinology, August 1, 2005; 146(8): 3481 - 3489.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
P. Monteleone, A. Tortorella, V. Martiadis, C. Serritella, A. Fuschino, and M. Maj
Opposite Changes in the Serum Brain-Derived Neurotrophic Factor in Anorexia Nervosa and Obesity
Psychosom Med, September 1, 2004; 66(5): 744 - 748.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Seki, T. Tanaka, H. Nawa, T. Usui, T. Fukuchi, K. Ikeda, H. Abe, and N. Takei
Involvement of Brain-Derived Neurotrophic Factor in Early Retinal Neuropathy of Streptozotocin-Induced Diabetes in Rats: Therapeutic Potential of Brain-Derived Neurotrophic Factor for Dopaminergic Amacrine Cells
Diabetes, September 1, 2004; 53(9): 2412 - 2419.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. Fox and M. S. Byerly
A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R994 - R1004.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Duan, Z. Guo, H. Jiang, M. Ware, X.-J. Li, and M. P. Mattson
Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice
PNAS, March 4, 2003; 100(5): 2911 - 2916.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. R. Goss, W. F. Goins, D. Lacomis, M. Mata, J. C. Glorioso, and D. J. Fink
Herpes Simplex-Mediated Gene Transfer of Nerve Growth Factor Protects Against Peripheral Neuropathy in Streptozotocin-Induced Diabetes in the Mouse
Diabetes, July 1, 2002; 51(7): 2227 - 2232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.